Literature DB >> 8000267

Dobutamine stress echocardiography in clinical practice with a review of the recent literature.

E Barasch1, S Wilansky.   

Abstract

Stress echocardiography has been developed in recent years as an effective noninvasive test for the detection and assessment of coronary artery disease. This method combines exercise with 2-dimensional echocardiography, which can assess regional and global left ventricular function during stress. Dobutamine infusion, a pharmacologic means of producing cardiovascular stress, appears to be an excellent alternative to exercise in echocardiographic studies. Currently, it is reserved for patients who cannot exercise at a meaningful level because of advanced age, physical deconditioning, or other factors. This review evaluates the current clinical application of dobutamine stress echocardiography and compares its efficacy with that of exercise echocardiography and nuclear perfusion imaging.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8000267      PMCID: PMC325166     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  41 in total

1.  Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery.

Authors:  D Poldermans; P M Fioretti; T Forster; I R Thomson; E Boersma; E M el-Said; N A du Bois; J R Roelandt; H van Urk
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

2.  Dobutamine stress echocardiography: prevalence of a nonischemic response in a low-risk population.

Authors:  D S Bach; A Hepner; P A Marcovitz; W F Armstrong
Journal:  Am Heart J       Date:  1993-05       Impact factor: 4.749

3.  Diagnosis of coronary artery disease in elderly patients: safety and efficacy of dobutamine echocardiography.

Authors:  T Baudhuin; T Marwick; J Melin; W Wijns; A M D'Hondt; J M Detry
Journal:  Eur Heart J       Date:  1993-06       Impact factor: 29.983

4.  Comparison of dobutamine stress echocardiography, dipyridamole stress echocardiography and exercise stress testing for diagnosis of coronary artery disease.

Authors:  M Previtali; L Lanzarini; R Fetiveau; A Poli; M Ferrario; C Falcone; A Mussini
Journal:  Am J Cardiol       Date:  1993-10-15       Impact factor: 2.778

5.  Demonstration of functional border zone with myocardial contrast echocardiography in human hearts. Simultaneous analysis of myocardial perfusion and wall motion abnormalities.

Authors:  S Nanto; T Masuyama; Y J Lim; M Hori; K Kodama; T Kamada
Journal:  Circulation       Date:  1993-08       Impact factor: 29.690

6.  Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization.

Authors:  C G Cigarroa; C R deFilippi; M E Brickner; L G Alvarez; M A Wait; P A Grayburn
Journal:  Circulation       Date:  1993-08       Impact factor: 29.690

7.  Assessment of thallium scintigraphy and echocardiography during dobutamine infusion for the detection of coronary artery disease.

Authors:  M F Warner; J J Pippin; G DiSciascio; W H Paulsen; J A Arrowood; J L Tatum; E Goudreau; G W Vetrovec
Journal:  Cathet Cardiovasc Diagn       Date:  1993-06

8.  Comparison of dobutamine and exercise echocardiography for detecting coronary artery disease.

Authors:  J L Cohen; J E Ottenweller; A K George; S Duvvuri
Journal:  Am J Cardiol       Date:  1993-12-01       Impact factor: 2.778

9.  Dynamic intraventricular obstruction during dobutamine stress echocardiography. A new observation.

Authors:  P A Pellikka; J K Oh; K R Bailey; B A Nichols; K H Monahan; A J Tajik
Journal:  Circulation       Date:  1992-11       Impact factor: 29.690

10.  Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability.

Authors:  P Marzullo; O Parodi; B Reisenhofer; G Sambuceti; E Picano; A Distante; A Gimelli; A L'Abbate
Journal:  Am J Cardiol       Date:  1993-01-15       Impact factor: 2.778

View more
  2 in total

1.  Contractility reserve in children undergoing dialysis by dobutamine stress echocardiography.

Authors:  Timur Mese; Baris Guven; Murat Muhtar Yilmazer; Erkin Serdaroglu; Vedide Tavli; Ali Haydar; Mustafa Bak
Journal:  Pediatr Cardiol       Date:  2010-05-19       Impact factor: 1.655

2.  A phase I study on pharmacokinetics and pharmacodynamics of higenamine in healthy Chinese subjects.

Authors:  Sheng Feng; Ji Jiang; Pei Hu; Jian-yan Zhang; Tao Liu; Qian Zhao; Bi-lu Li
Journal:  Acta Pharmacol Sin       Date:  2012-10-22       Impact factor: 6.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.